NATCO PHARMA
Quarterly Results Analysis [Jun2026]
NATCO PHARMA Quarterly Results
| Consolidated | Jun2026 UnAudited |
Mar2026 UnAudited |
Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹735 Cr | ₹739 Cr | ₹647 Cr | ₹1,363 Cr | ₹1,329 Cr | ₹1,221 Cr | ₹475 Cr | ₹1,371 Cr |
| Expenses | ₹549 Cr | ₹612 Cr | ₹489 Cr | ₹784 Cr | ₹758 Cr | ₹673 Cr | ₹436 Cr | ₹567 Cr |
| Operating Income | ₹187 Cr | ₹128 Cr | ₹159 Cr | ₹579 Cr | ₹571 Cr | ₹548 Cr | ₹39 Cr | ₹804 Cr |
| Other Income | ₹59 Cr | ₹78 Cr | ₹58 Cr | ₹100 Cr | ₹62 Cr | ₹66 Cr | ₹176 Cr | ₹64 Cr |
| Interest | ₹13 Cr | ₹11 Cr | ₹10 Cr | ₹13 Cr | ₹3 Cr | ₹10 Cr | ₹4 Cr | ₹4 Cr |
| Depreciation | ₹47 Cr | ₹50 Cr | ₹46 Cr | ₹52 Cr | ₹58 Cr | ₹98 Cr | ₹47 Cr | ₹46 Cr |
| Profit Before Tax | ₹186 Cr | ₹144 Cr | ₹161 Cr | ₹614 Cr | ₹572 Cr | ₹506 Cr | ₹164 Cr | ₹818 Cr |
| Profit After Tax | ₹122 Cr | ₹233 Cr | ₹140 Cr | ₹518 Cr | ₹480 Cr | ₹406 Cr | ₹132 Cr | ₹677 Cr |
| EPS | ₹11.54 | ₹14.97 | ₹8.46 | ₹28.96 | ₹26.85 | ₹22.72 | ₹7.43 | ₹37.84 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| NATCO PHARMA | -3.4% | -8.3% | -2.8% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.5% | -4% | 15.7% |
| DIVIS LABORATORIES | 9.1% | 18.2% | 47.1% |
| TORRENT PHARMACEUTICALS | 3.6% | 3.4% | 36.4% |
| CIPLA | -1.2% | -3.3% | -10.8% |
| DR REDDYS LABORATORIES | -1.4% | 2.9% | -8% |
| MANKIND PHARMA | 0.5% | -7.4% | -7.3% |
| LUPIN | -0.7% | -10.1% | 9.6% |
| ZYDUS LIFESCIENCES | 7.8% | 6.4% | 20.3% |
NATCO PHARMA Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | -0.53 % |
| Y-o-Y | -44.68 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Jun2026 | ₹735 Cr | -0.53 | |
| Mar2026 | ₹739 Cr | 14.18 | |
| Dec2025 | ₹647 Cr | -52.51 | |
| Sep2025 | ₹1,363 Cr | 2.57 | |
| Jun2025 | ₹1,329 Cr | 8.84 | |
| Mar2025 | ₹1,221 Cr | 157.16 | |
| Dec2024 | ₹475 Cr | -65.37 | |
| Sep2024 | ₹1,371 Cr | - | |
NATCO PHARMA Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 46.16 % |
| Y-o-Y | -67.34 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Jun2026 | ₹187 Cr | 46.16 | |
| Mar2026 | ₹128 Cr | -19.60 | |
| Dec2025 | ₹159 Cr | -72.60 | |
| Sep2025 | ₹579 Cr | 1.44 | |
| Jun2025 | ₹571 Cr | 4.18 | |
| Mar2025 | ₹548 Cr | 1,312.63 | |
| Dec2024 | ₹39 Cr | -95.18 | |
| Sep2024 | ₹804 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 46.99 % |
| Y-o-Y | -40.96 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Jun2026 | 25.37% | 46.99 | |
| Mar2026 | 17.26% | -29.61 | |
| Dec2025 | 24.52% | -42.29 | |
| Sep2025 | 42.49% | -1.12 | |
| Jun2025 | 42.97% | -4.28 | |
| Mar2025 | 44.89% | 449.45 | |
| Dec2024 | 8.17% | -86.07 | |
| Sep2024 | 58.66% | - | |
NATCO PHARMA Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | -47.62 % |
| Y-o-Y | -74.56 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Jun2026 | ₹122 Cr | -47.62 | |
| Mar2026 | ₹233 Cr | 66.17 | |
| Dec2025 | ₹140 Cr | -72.89 | |
| Sep2025 | ₹518 Cr | 7.83 | |
| Jun2025 | ₹480 Cr | 18.30 | |
| Mar2025 | ₹406 Cr | 206.65 | |
| Dec2024 | ₹132 Cr | -80.43 | |
| Sep2024 | ₹677 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | -47.36 % |
| Y-o-Y | -54.01 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Jun2026 | 16.62 % | -47.36 | |
| Mar2026 | 31.57 % | 45.55 | |
| Dec2025 | 21.69 % | -42.92 | |
| Sep2025 | 38 % | 5.15 | |
| Jun2025 | 36.14 % | 8.69 | |
| Mar2025 | 33.25 % | 19.22 | |
| Dec2024 | 27.89 % | -43.47 | |
| Sep2024 | 49.34 % | - | |
NATCO PHARMA Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | -22.91 % |
| Y-o-Y | -57.02 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Jun2026 | ₹11.54 | -22.91 | |
| Mar2026 | ₹14.97 | 76.95 | |
| Dec2025 | ₹8.46 | -70.79 | |
| Sep2025 | ₹28.96 | 7.86 | |
| Jun2025 | ₹26.85 | 18.18 | |
| Mar2025 | ₹22.72 | 205.79 | |
| Dec2024 | ₹7.43 | -80.36 | |
| Sep2024 | ₹37.84 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD